CDKAL1 and type 2 diabetes mellitus: Related to the latter, mutations in aaRSs [75,76,77,78,79,80,81,82] and intronic variants in the tRNA-modifying enzyme CDKAL1 [83,84,85] have been associated with increased risk for T2D and obesity.